Development of two novel monoclonal antibodies against overexpressed antigens on pancreatic cancer cells for use in diagnosis and therapy

GA Arias Pinilla; AG Dalgleish; S Mudan; I Bagwan; AJ Walker; H Modjtahedi

doi:10.1136/esmoopen-2018-EACR25.576

Development of two novel monoclonal antibodies against overexpressed antigens on pancreatic cancer cells for use in diagnosis and therapy

GA Arias Pinilla, AG Dalgleish, S Mudan, I Bagwan, AJ Walker, H Modjtahedi

Research output: Contribution to conference › Poster › peer-review

Original language	English
DOIs	https://doi.org/10.1136/esmoopen-2018-EACR25.576
Publication status	Published - 30 Jun 2018
Event	25th Biennial Congress of the European Association for Cancer Research (EACR25) : From Fundamental Insight to Rational Cancer Treatment - Amsterdam, The Netherlands Duration: 30 Jun 2018 → 3 Jul 2018

Conference

Conference	25th Biennial Congress of the European Association for Cancer Research (EACR25) : From Fundamental Insight to Rational Cancer Treatment
Period	30/06/18 → 3/07/18

Bibliographical note

Note: An abstract of this poster was published in ESMO Open, 2018, Volume 3 (Supplement 2), within a section called EACR 25 - Congress Abstracts. Monday Poster Presentation. Experimental/Molecular Therapeutics, Pharmacogenomics. New Therapies. It is on p. A244.

Organising Body: European Association for Cancer Research

Keywords

Cancer studies

Access to Document

10.1136/esmoopen-2018-EACR25.576

Arias-Pinilla-G-A-48053-VoRFinal published version, 75.4 KBLicence: CC BY-NC

https://doi.org/10.1136/esmoopen-2018-EACR25.576

Cite this

Arias Pinilla, GA., Dalgleish, AG., Mudan, S., Bagwan, I., Walker, AJ., & Modjtahedi, H. (2018). Development of two novel monoclonal antibodies against overexpressed antigens on pancreatic cancer cells for use in diagnosis and therapy. Poster session presented at 25th Biennial Congress of the European Association for Cancer Research (EACR25) : From Fundamental Insight to Rational Cancer Treatment. https://doi.org/10.1136/esmoopen-2018-EACR25.576

@conference{b1dacfca05e942e4ad33a2e8dea9f14a,

title = "Development of two novel monoclonal antibodies against overexpressed antigens on pancreatic cancer cells for use in diagnosis and therapy",

keywords = "Cancer studies",

author = "\{Arias Pinilla\}, GA and AG Dalgleish and S Mudan and I Bagwan and AJ Walker and H Modjtahedi",

note = "Note: An abstract of this poster was published in ESMO Open, 2018, Volume 3 (Supplement 2), within a section called EACR 25 - Congress Abstracts. Monday Poster Presentation. Experimental/Molecular Therapeutics, Pharmacogenomics. New Therapies. It is on p. A244. Organising Body: European Association for Cancer Research; 25th Biennial Congress of the European Association for Cancer Research (EACR25) : From Fundamental Insight to Rational Cancer Treatment ; Conference date: 30-06-2018 Through 03-07-2018",

year = "2018",

month = jun,

day = "30",

doi = "10.1136/esmoopen-2018-EACR25.576",

language = "English",

}

Arias Pinilla, GA, Dalgleish, AG, Mudan, S, Bagwan, I, Walker, AJ & Modjtahedi, H 2018, 'Development of two novel monoclonal antibodies against overexpressed antigens on pancreatic cancer cells for use in diagnosis and therapy', 25th Biennial Congress of the European Association for Cancer Research (EACR25) : From Fundamental Insight to Rational Cancer Treatment, 30/06/18 - 3/07/18. https://doi.org/10.1136/esmoopen-2018-EACR25.576

Development of two novel monoclonal antibodies against overexpressed antigens on pancreatic cancer cells for use in diagnosis and therapy. / Arias Pinilla, GA; Dalgleish, AG; Mudan, S et al.
2018. Poster session presented at 25th Biennial Congress of the European Association for Cancer Research (EACR25) : From Fundamental Insight to Rational Cancer Treatment.

Research output: Contribution to conference › Poster › peer-review

TY - CONF

T1 - Development of two novel monoclonal antibodies against overexpressed antigens on pancreatic cancer cells for use in diagnosis and therapy

AU - Arias Pinilla, GA

AU - Dalgleish, AG

AU - Mudan, S

AU - Bagwan, I

AU - Walker, AJ

AU - Modjtahedi, H

N1 - Note: An abstract of this poster was published in ESMO Open, 2018, Volume 3 (Supplement 2), within a section called EACR 25 - Congress Abstracts. Monday Poster Presentation. Experimental/Molecular Therapeutics, Pharmacogenomics. New Therapies. It is on p. A244. Organising Body: European Association for Cancer Research

PY - 2018/6/30

Y1 - 2018/6/30

KW - Cancer studies

U2 - 10.1136/esmoopen-2018-EACR25.576

DO - 10.1136/esmoopen-2018-EACR25.576

M3 - Poster

T2 - 25th Biennial Congress of the European Association for Cancer Research (EACR25) : From Fundamental Insight to Rational Cancer Treatment

Y2 - 30 June 2018 through 3 July 2018

ER -

Arias Pinilla GA, Dalgleish AG, Mudan S, Bagwan I, Walker AJ , Modjtahedi H. Development of two novel monoclonal antibodies against overexpressed antigens on pancreatic cancer cells for use in diagnosis and therapy. 2018. Poster session presented at 25th Biennial Congress of the European Association for Cancer Research (EACR25) : From Fundamental Insight to Rational Cancer Treatment. doi: 10.1136/esmoopen-2018-EACR25.576